ICON Signs Collaboration Agreement with the Taiwan National Centre of Excellence for Clinical Trials and Research
ICON plc, (NASDAQ: ICLR)a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and the National Clinical Trials and Research Centre (NCTRC) at theNational Taiwan University Hospital, today announced a collaboration agreement to enhance the set-up and management of clinical studies in Taiwan.
ICON plc
, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and the
National Clinical Trials and Research Centre
(NCTRC) at the
National Taiwan University Hospital
, today announced a collaboration agreement to enhance the set-up and management of clinical studies in Taiwan.
Under the terms of the agreement NCTRC and ICON will work together on study start-up, site feasibility, key site and investigator selection and patient recruitment. Both organizations will also work together on further enhancing the already high standards of clinical research in Taiwan.
“We are very pleased to be collaborating with the NCTRC who are at the forefront of clinical research in Taiwan,” commented Wei Ming Goh, ICON’s Vice President, Asia-Pacific. “Our customers are increasingly looking to include Taiwan in their clinical programs and are expecting fast timelines for study start-up and patient recruitment. By combining the proven expertise of ICON and NCTRC in the region, we can further accelerate study timelines which will benefit our customers and also enhance the Taiwanese clinical trials industry.”
“The aim of this partnership is to accelerate new drug development and new treatments for diseases and we hope to achieve this by leveraging our respective strengths,” commented Professor Chan Wing Kai, Director of NCTRC. “We are happy to be collaborating with ICON, a leading clinical research organization that has proven experience in both global and local clinical development programs.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
